Once weekly insulin: Reinventing the insulin experience

Novo Nordisk A/S |
Thursday

Chair: Tina Vilsbøll (DNK)

14:15 – 14:19Welcome and introductionsTina Vilsbøll (DNK)
14:19 – 14:28First phase 3 evidence for a once-weekly insulin

Athena Philis-Tsimikas (USA)
Stephen Bain (UK)

14:28 – 14:45Advancing diabetes management with once-weekly insulin
Panel discussion and Q&A
All faculty